Anne Kimmerlein

Dr. Anne Kimmerlein

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
AKAnne Kimmerlein
Anne Kimmerlein
TMTalon S. McKee
Talon S. McKee
PBPhilip J. Bergman
Philip J. Bergman
ISIrina Sokolchik
Irina Sokolchik
CLChristian M. Leutenegger
Christian M. Leutenegger
Recent emerging zoonotic disease outbreaks, such as that of SARS-CoV-2, have demonstrated the need for wider companion animal disease surveillance. We tested 1000 dogs and cats belonging to employees of a US veterinary hospital network that were exposed to human COVID-19 cases in the household between 1 January 2020 and 10 March 2022 for SARS-CoV-2 and surveyed their owners about clinical signs and risk factors. The seropositivity was 33% for 747 dogs and 27% for 253 cats. Pet seropositivity correlated with the US human case rates over time, exhibiting peaks corresponding with the major COVID-19 surges. Antibodies persisted longer than previously documented (828 days in dogs; 650 days in cats). Increasing age and duration of proximity to infected people were associated with increased seropositivity in dogs but not cats. Cats were more likely to have clinical signs, but an association between seropositivity and the presence of clinical signs was not found in either species.

1 May 2024 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
JWJ. Scott Weese
J. Scott Weese
MMMargo Mosher
Margo Mosher
RLRochelle Low
Rochelle Low
EWEllie West
Ellie West
BOBen O'KElley
Ben O'KElley
IBIan Battersby
Ian Battersby
Background: Measuring antimicrobial use is a core component of antimicrobial stewardship. Purchasing data may be easier to obtain than prescription data in some situations, but differences in clinic size, caseload and collection timeframes must be considered. Objective: Our objective was to evaluate purchases of systemic antibacterial agents by small animal veterinary facilities in 5 networks across 3 countries, using a mg/veterinarian full time equivalent (FTE)/week as the metric. Methods: Data were obtained from purchasing records of 2194 veterinary facilities from networks from the United States (US, n = 3: US-A, 1036 facilities; US-B, 101 facilities; US-C, 886 facilities), Canada (n = 1: 117 facilities) and the United Kingdom (UK, n = 1: 54 facilities) during 2019-2021. Results: In total, 20 020 269 767 mg (20.02 t) of antimicrobials were purchased. Overall differences between the UK and North America were driven by significantly higher purchases of amoxicillin-clavulanic acid in the UK (P < .001), with substantially less purchasing of third generation cephalosporins in the UK (P < .0001). A significant association was found between FTE and purchasing, with decreased purchasing (mg/FTE/week) as facility FTE increased. Significant differences also were found among US regions. Facilities in the top 10% of total purchasing accounted for 23%-30% of purchases, compared to only 1.6%-3.8% for the bottom 10%. Conclusions and Clinical Importance: These data provide useful information about general purchasing trends, inter- and intraregional differences and differences among facility types and identify high purchasing outliers for further investigation.

17 November 2026 in American Journal of Veterinary Research
Verified
Journal Article
Open access
ETEmily Teng
Emily Teng
AKAnne Kimmerlein
Anne Kimmerlein
PCPablo Jimenez Castro
Pablo Jimenez Castro
MKMarie E. Kerl
Marie E. Kerl
MEMichelle Evason
Michelle Evason
CLChristian M. Leutenegger
Christian M. Leutenegger
Objective: To describe the geographic distribution and clinical features of dogs and cats with Baylisascaris procyonis detected by fecal quantitative PCR (qPCR). Methods: Dogs and cats in the US and Canada that were diagnosed with B procyonis via fecal qPCR performed by a veterinary diagnostic laboratory from March 3, 2022, through November 1, 2023, were identified. Details about patient demographics, clinical signs, treatment, and outcome were retrospectively captured via questionnaires sent to each pet’s primary care veterinarian. Descriptive statistics were calculated. Results: B procyonis was detected in 74 dogs and 3 cats through fecal qPCR screening. Dogs were from Canada (n = 22) and the US (52), and cats were from the US (3). The US-detected samples were from the Midwest (35%) and Northeast (22%). Most US-detected cases (69%) resided in a suburban environment, and most Canadian cases (80%) resided in an urban environment. Clinical signs were not reported in most (62%) cases with fecal qPCR-detected B procyonis . Gastrointestinal signs were reported in 36% of cases, and resolution of gastrointestinal signs following anthelmintic treatment was reported in most (72.9%) of those. Conclusions: The geographic distribution of detected B procyonis in dogs and cats is similar to that reported in raccoons. Reported clinical disease appears mild and responsive to anthelmintic treatment in most dogs and cats. Clinical Relevance: Veterinarian awareness of risk regions for raccoon roundworm detection is critical for One Health. Detection of B procyonis through routine fecal screening of dogs and cats informs risk of environmental exposure and zoonoses and allows for targeted antiparasitic prevention.

7 October 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MWMargaret Wingerd
Margaret Wingerd
AKAnne Kimmerlein
Anne Kimmerlein
PCPablo Jimenez Castro
Pablo Jimenez Castro
MEMichelle D. Evason
Michelle D. Evason
JWJennifer L. Willcox
Jennifer L. Willcox
MKMarie E. Kerl
Marie E. Kerl
Giardia duodenalis is a flagellated commensal protozoan that can infect both humans and animals. Infection can result in clinical signs such as diarrhea or, more often, the infection can be subclinical. Within the G. duodenalis species, there are several major genetic assemblages, A – H. Certain assemblages are species specific (C and D in dogs, F in cats) while assemblages A and B can infect humans as well as other mammals. This retrospective study used data collected from a commercial reference laboratory (Antech Diagnostics, Mars Petcare Science & Diagnostics). Real-time PCR data using fecal qPCR panel (KeyScreen™ GI Parasite PCR) for Giardia duodenalis and potential zoonotic assemblages A/B in 157,616 domestic cat stool samples from North America collected between March 8, 2022, to August 31, 2023, was used. Variables including age, sex, altered status, season, and geographic region were assessed to identify associations with cats that were detected for G. duodenalis and potential zoonotic assemblages A/B. The overall prevalence of G. duodenalis was 6.3% (9,962/157,616) and of those detected, 18.5% (1,840/9,962) were assemblages A/B. Cats that were G. duodenalis detected were more likely to be male, intact, less than one-year old, and in the Midwest. In general, lowest detection occurred during the summer months. Zoonotic potential detection was highest in cats aged less than one-year (19.7%; 1,011/5,137). These data highlight the importance of routine fecal screening in domestic cats to detect parasites, particularly those, like Giardia , of One Health concern, and provides prevalence, and risk factor information that aids clinical veterinary decision-making.